These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 3876335
1. Photoinactivation of B-type monoamine oxidase by a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite. Buckman TD, Eiduson S. J Biol Chem; 1985 Oct 05; 260(22):11899-902. PubMed ID: 3876335 [Abstract] [Full Text] [Related]
2. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase. Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M. J Pharmacol Exp Ther; 1986 Aug 05; 238(2):648-52. PubMed ID: 3488394 [Abstract] [Full Text] [Related]
3. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity. Kinemuchi H, Arai Y, Toyoshima Y. Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524 [Abstract] [Full Text] [Related]
4. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine. Takamidoh H, Naoi M, Nagatsu T. Neurosci Lett; 1987 Jan 27; 73(3):293-7. PubMed ID: 3494215 [Abstract] [Full Text] [Related]
5. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Singer TP, Salach JI, Crabtree D. Biochem Biophys Res Commun; 1985 Mar 15; 127(2):707-12. PubMed ID: 3872126 [Abstract] [Full Text] [Related]
6. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. Fritz RR, Abell CW, Patel NT, Gessner W, Brossi A. FEBS Lett; 1985 Jul 08; 186(2):224-8. PubMed ID: 3874094 [Abstract] [Full Text] [Related]
8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM. J Neurochem; 1990 Sep 08; 55(3):870-7. PubMed ID: 2384758 [Abstract] [Full Text] [Related]
9. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B. Heikkila RE, Duvoisin RC, Finberg JP, Youdim MB. Eur J Pharmacol; 1985 Oct 22; 116(3):313-7. PubMed ID: 3935467 [Abstract] [Full Text] [Related]
10. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1985 Mar 22; 232(3):696-701. PubMed ID: 3871853 [Abstract] [Full Text] [Related]
11. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Peterson LA, Caldera PS, Trevor A, Chiba K, Castagnoli N. J Med Chem; 1985 Oct 22; 28(10):1432-6. PubMed ID: 3876442 [Abstract] [Full Text] [Related]
12. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B. Ottoboni S, Caldera P, Trevor A, Castagnoli N. J Biol Chem; 1989 Aug 15; 264(23):13684-8. PubMed ID: 2788162 [Abstract] [Full Text] [Related]
13. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation. Hiebert CK, Sayre LM, Silverman RB. J Biol Chem; 1989 Dec 25; 264(36):21516-21. PubMed ID: 2600079 [Abstract] [Full Text] [Related]
14. Inhibition of rat brain monoamine oxidase by some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion. Arai Y, Kinemuchi H, Hamamichi N, Satoh N, Tadano T, Kisara K. Neurosci Lett; 1986 May 06; 66(1):43-8. PubMed ID: 3487053 [Abstract] [Full Text] [Related]
15. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates. Kalgutkar AS, Castagnoli K, Hall A, Castagnoli N. J Med Chem; 1994 Apr 01; 37(7):944-9. PubMed ID: 8151621 [Abstract] [Full Text] [Related]
16. Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary. Gibb C, Willoughby J, Glover V, Sandler M, Testa B, Jenner P, Marsden CD. Neurosci Lett; 1987 May 19; 76(3):316-22. PubMed ID: 3495757 [Abstract] [Full Text] [Related]
17. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Salach JI, Singer TP, Castagnoli N, Trevor A. Biochem Biophys Res Commun; 1984 Dec 14; 125(2):831-5. PubMed ID: 6335034 [Abstract] [Full Text] [Related]
18. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Kalaria RN, Mitchell MJ, Harik SI. Proc Natl Acad Sci U S A; 1987 May 14; 84(10):3521-5. PubMed ID: 3495000 [Abstract] [Full Text] [Related]
19. Oxidation of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine, a 1-amino analog of MPTP, by type A and B monoamine oxidase. Umeda M, Aoyama S, Kaiya T, Kohda K, Maruyama W, Naoi M. J Neural Transm (Vienna); 1998 May 14; 105(10-12):1253-64. PubMed ID: 9928894 [Abstract] [Full Text] [Related]
20. Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues. Glover V, Gibb C, Sandler M. Neurosci Lett; 1986 Feb 28; 64(2):216-20. PubMed ID: 3083305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]